US biopharma Insmed Incorporated has announced that the Phase IIb BiRCh study of brensocatib in chronic rhinosinusitis ...

US biotech VYNE Therapeutics has agreed to merge with privately held Yarrow Bioscience in an all-stock transaction, pivoting ...

US biotech Cytokinetics (Nasdaq: CYTK) has secured the first global approval for its cardiac myosin inhibitor aficamten, ...

Japanese drugmaker Takeda has announced positive topline results for two pivotal Phase III studies of zasocitinib (TAK-279), ...

Sino-US biotech Harbour BioMed, which is focused on the discovery and development of novel antibody therapeutics in ...

UK pharma major GSK yesterday announced that the US Food and Drug Administration (FDA) has approved Exdensur ...

US biotech Incyte yesterday revealed that the European Commission (EC) has approved Minjuvi (tafasitamab) in combination with ...

USA and Europe listed biotech PureTech has appointed Robert Lyne as chief executive (CEO), and as a member of the board of ...

US venture firm MBX Capital has crossed $100 million in cumulative capital commitments to invest in early-stage biotech and ...

Switzerland-based Topadur Pharma, a biotech company developing innovative therapies for vascular regeneration, has announced ...

German biotech T-CURX today announced the first closing of a $20 million (17.7 million) Series A financing with a syndicate ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a new indication for Dutch immunology company ...